Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
PLoS One ; 19(8): e0309304, 2024.
Article de Anglais | MEDLINE | ID: mdl-39173020

RÉSUMÉ

The aim of this study was to investigate the prevalence of Vibrionaceae family in retail seafood products available in the Qidong market during the summer of 2023 and to characterize Vibrio parahaemolyticus isolates, given that this bacterium is the leading cause of seafood-associated food poisoning. We successfully isolated a total of 240 Vibrionaceae strains from a pool of 718 seafood samples. The breakdown of the isolates included 146 Photobacterium damselae, 59 V. parahaemolyticus, 18 V. campbellii, and 11 V. alginolyticus. Among these, P. damselae and V. parahaemolyticus were the predominant species, with respective prevalence rates of 20.3% and 8.2%. Interestingly, all 59 isolates of V. parahaemolyticus were identified as non-pathogenic. They demonstrated proficiency in swimming and swarming motility and were capable of forming biofilms across a range of temperatures. In terms of antibiotic resistance, the V. parahaemolyticus isolates showed high resistance to ampicillin, intermediate resistance to cefuroxime and cefazolin, and were sensitive to the other antibiotics evaluated. The findings of this study may offer valuable insights and theoretical support for enhancing seafood safety measures in Qidong City.


Sujet(s)
Produits de la mer , Vibrio parahaemolyticus , Produits de la mer/microbiologie , Vibrio parahaemolyticus/isolement et purification , Vibrio parahaemolyticus/effets des médicaments et des substances chimiques , Vibrio parahaemolyticus/génétique , Microbiologie alimentaire , Prévalence , Chine/épidémiologie , Vibrionaceae/génétique , Vibrionaceae/isolement et purification , Vibrionaceae/effets des médicaments et des substances chimiques , Antibactériens/pharmacologie , Tests de sensibilité microbienne , Biofilms/croissance et développement , Biofilms/effets des médicaments et des substances chimiques , Résistance bactérienne aux médicaments
2.
Gut Pathog ; 16(1): 40, 2024 Jul 29.
Article de Anglais | MEDLINE | ID: mdl-39075606

RÉSUMÉ

Vibrio vulnificus, a significant marine pathogen, undergoes opaque (Op)-translucent (Tr) colony switching based on whether capsular polysaccharide (CPS) is produced. CPS phase variation is sometime accompanied by genetic variation or down-regulation of particular genes, such as wzb. In addition, CPS prevents biofilm formation and is important to the virulence of V. vulnificus. However, the extent to which there is a difference in gene expression between Tr and Op colonies and the impact of CPS phase variation on other behaviors of V. vulnificus remain unknown. In this work, the data have shown that CPS phase variation of V. vulnificus is affected by incubation time. Tr and Op strains exhibited similar growth rates. However, Tr strains had enhanced biofilm formation capacities but reduced swimming motility compared to Op strains. The RNA-seq assay revealed 488 differentially expressed genes, with 214 downregulated and 274 upregulated genes, between Tr and Op colonies. Genes associated with Tad pili and CPS were downregulated, whereas those involved in flagellum were upregulated, in Tr colonies compared with Op colonies. In addition, 9 putative c-di-GMP metabolism-associated genes and 28 genes encoding putative regulators were significantly differentially expressed, suggesting that CPS phase variation is probably strictly regulated in V. vulnificus. Moreover, 8 genes encoding putative porins were also differentially expressed between the two phenotypic colonies, indicating that bacterial outer membrane was remodeled during CPS phase variation. In brief, this work highlighted the gene expression profiles associated with CPS phase variation, but more studies should be performed to disclose the intrinsic mechanisms in the future.

3.
Arch Microbiol ; 206(7): 321, 2024 Jun 22.
Article de Anglais | MEDLINE | ID: mdl-38907796

RÉSUMÉ

Vibrio parahaemolyticus possesses two distinct type VI secretion systems (T6SS), namely T6SS1 and T6SS2. T6SS1 is predominantly responsible for adhesion to Caco-2 and HeLa cells and for the antibacterial activity of V. parahaemolyticus, while T6SS2 mainly contributes to HeLa cell adhesion. However, it remains unclear whether the T6SS systems have other physiological roles in V. parahaemolyticus. In this study, we demonstrated that the deletion of icmF2, a structural gene of T6SS2, reduced the biofilm formation capacity of V. parahaemolyticus under low salt conditions, which was also influenced by the incubation time. Nonetheless, the deletion of icmF2 did not affect the biofilm formation capacity in marine-like growth conditions, nor did it impact the flagella-driven swimming and swarming motility of V. parahaemolyticus. IcmF2 was found to promote the production of the main components of the biofilm matrix, including extracellular DNA (eDNA) and extracellular proteins, and cyclic di-GMP (c-di-GMP) in V. parahaemolyticus. Additionally, IcmF2 positively influenced the transcription of cpsA, mfpA, and several genes involved in c-di-GMP metabolism, including scrJ, scrL, vopY, tpdA, gefA, and scrG. Conversely, the transcription of scrA was negatively impacted by IcmF2. Therefore, IcmF2-dependent biofilm formation was mediated through its effects on the production of eDNA, extracellular proteins, and c-di-GMP, as well as its impact on the transcription of cpsA, mfpA, and genes associated with c-di-GMP metabolism. This study confirmed new physiological roles for IcmF2 in promoting biofilm formation and c-di-GMP production in V. parahaemolyticus.


Sujet(s)
Protéines bactériennes , Biofilms , GMP cyclique , Systèmes de sécrétion de type VI , Vibrio parahaemolyticus , Vibrio parahaemolyticus/génétique , Vibrio parahaemolyticus/physiologie , Vibrio parahaemolyticus/métabolisme , Biofilms/croissance et développement , Systèmes de sécrétion de type VI/génétique , Systèmes de sécrétion de type VI/métabolisme , Protéines bactériennes/génétique , Protéines bactériennes/métabolisme , GMP cyclique/analogues et dérivés , GMP cyclique/métabolisme , Humains , Régulation de l'expression des gènes bactériens , Cellules HeLa
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE